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 Although modest and progressive improve-
ments have been made, survival rates of 
conventionally treated hemodialysis 
and the exact mechanisms leading to FP 
eff acement and proteinuria in RhoA over- 
and underactivity, as well as how they 
functionally interact with the large GTPase 
dynamin that is heavily expressed in podo-
cyte FPs to also regulate F-actin organiza-
tion and fi lter operation. 1 
 Given the complexity of the functional 
role of small GTPases in podocyte FPs, the 
study by Wang  et al. 9 puts forward valuable 
novel  in vivo information for a  fascinating 
and expanding topic in glomerular biology: 
the tuning of kidney filter function by 
means of podocyte dynamics. 
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 Alternate-day dialysis may be 
needed for hemodialysis patients 
 Jiannong  Liu 1 and  Robert N.  Foley 1 , 2 
 Zhang  et al. studied the relationship between day of the week and all-
cause and cardiovascular mortality in the United States, Europe, and 
Japan. The study confirms findings of studies of US patients that risk of 
all-cause and cardiac mortality is higher after a long interdialytic 
interval, and shows that this is also true in Europe and Japan. Alternate-
day dialysis may improve patient survival on hemodialysis, but 
randomized trials are necessary to establish a new schedule. 
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patients remain disappointing. 1 As has 
long been the case, most hemodialysis 
patients worldwide continue to receive 
maintenance treatment three times a week, 
with a 2 – day interval at weekends, a stand-
ard of practice that lacks the solid founda-
tion of randomized trial. To an external 
observer (armed with the knowledge that 
overt cardiovascular disease is typically 
present and uremia, in and of itself, limits 
the ability to deal with hypervolemia, 
hypovolemia, and hyperkalemia), the fact 
that standard practice mandates a 2-day 
interval between treatments might be 
counterintuitive. 
 Hemodialysis three times per week 
gives patients a 2-day interdialytic interval 
from Friday to Monday or from Saturday 
to Tuesday. Bleyer  et al. , 2 using United 
States Renal Data System data from the 
1990s, showed that all hemodialysis 
patients experienced higher risk of sud-
den and cardiac death on Monday and 
Tuesday — whether schedules were 
Monday – Wednesday – Friday (MWF) or 
Tuesday – Th ursday – Saturday (TTS) was 
unknown — and showed similar fi ndings 
in a well-characterized subset whose 
schedules were known, with the highest 
mortality rates on Mondays for MWF and 
Tuesdays for TTS patients. It is reasonable 
to assume that risk was higher on Mon-
days for patients on an MWF schedule 
and on Tuesdays for patients on a TTS 
schedule. Non-cardiac death was more 
evenly distributed in hemodialysis 
patients. In contrast, sudden death and 
cardiac death were more evenly distrib-
uted among peritoneal dialysis patients. 
Foley  et al. 3 recently confi rmed these fi nd-
ings in more contemporary US hemodi-
alysis patients, with a clearly higher risk of 
all-cause mortality and cause-specific 
mortality (cardiac, infectious, cardiac 
arrest, and myocardial infarction) and 
higher risk of myocardial infarction, con-
gestive heart failure, stroke, and dysrhyth-
mia hospitalizations on the day aft er the 
long interdialytic interval. 
 Zhang  et al. 4 (this issue), using data 
from the Dialysis Outcomes and Practice 
Patterns Study (DOPPS), confirm the 
fi ndings of previous studies in US hemo-
dialysis patients and, importantly, extend 
the observations to European and 
Japanese hemodialysis patients. As comor-
bidity, catheter use, and likelihood of skip-
ping dialysis sessions are higher in the 
United States than in Europe or Japan, and 
dialysis times are shorter, fi ndings from 
the DOPPS suggest that the fi ndings from 
the previous studies are not confi ned to 
the United States and are not completely 
explained by the burden of comorbidity, 
catheter use, missed treatments, and 
shorter dialysis times. 
 The study by Zhang and colleagues 4 
shows additional mortality patterns not 
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seen in the above-mentioned studies. For 
example, in Japan, mortality rates were 
dramatically higher on the day of the last 
dialysis session of the week. In Europe, a 
similar fi nding was present, but confi ned 
to patients on TTS schedules. Th e authors 
speculate that these unexpected fi ndings 
reflect more aggressive fluid-removal 
practices late in the week, making room, 
as it were, for additional fl uid accumula-
tion at the weekend. It seems diffi  cult to 
imagine that such a practice could lead to 
a sudden doubling of mortality rates. In 
addition, one would expect that dry 
weight would usually be constant for each 
session of the dialysis week, and system-
atically attempting to go below dry weight 
every third hemodialysis session would 
not be recommended practice. 
 Some methodological issues are worth 
emphasizing. Although a question such as 
 ‘ Is mortality higher on Monday than on 
Tuesday? ’ seems quite straightforward, it 
can be answered in many ways. In the 
study by Zhang  et al. , 4 mortality estimates 
on a given day were compared with the 
overall average for the week. As such a 
strategy was not used in the other studies 
described above, the Zhang  et al. study 
tends to underestimate risk ratios when 
compared with the previous studies. If 
hypothetical rates from day 1 to day 7 were 
10, 1, 1, 1, 1, 1, and 1, the weekly average 
would be 2.3. With the average of Tuesday 
to Sunday as the reference, the relative risk 
of Monday would be 10, whereas with the 
method used by Zhang  et al. , the relative 
risk would be 4.4 ( Figure 1 ). Finally, the 
time-dependent covariate analysis is con-
ceptually challenging. With a typical, con-
ditional time-dependent covariate with 
two options (present or absent) available 
for a given date, one would expect that 
a given option could occur on a given 
day without predetermination. Similar 
comments apply to a situation with seven 
potential options. For day of the week, 
the only factor dependent on the play 
of chance should be the fi rst day of follow-
up. In other words, once the first day 
is known, the nature of all subsequent 
days becomes known, which seems to 
imply predetermination. 
 Methodological niceties aside, many of 
the fi ndings of Zhang  et al. 4 are in good 
agreement with previous fi ndings. As these 
findings are not based on randomized 
treatment assignment, cause and eff ect 
claims are moot. However, the observa-
tions in the study by Zhang  et al. have 
implications that diff er from those of most 
observational studies. Observational stud-
ies typically examine diff erent levels (for 
example, high versus low) of a candidate 
parameter within the study population for 
association with outcomes (such as death). 
If one fi nds that a high level is associated 
with higher death rates, it is impossible to 
refute the counter-hypothesis that some 
unmeasured, uneq ually distributed factor 
accounts for the association. Unmeasured 
factors within the study population cannot 
explain variability in day-to-day mortality, 
as the same population is used to compute 
mortality rates on each separate day. 
Although hemodialysis schedule confi gu-
rations seem the most likely explanation 
for the observations in all these studies, it 
is impossible to refute the counter-
hypothesis that some other unmeasured 
time-varying factor, extraneous to the 
study, explains the different mortality 
rates. It is diffi  cult to conceptualize a factor 
that would  ‘ know ’ that it should apply itself 
on Mondays in some subjects and on Tues-
days in others. Although unmeasured 
comorbidity cannot explain day-to-day 
mortality variation, it is quite plausible 
that the degree of variation could diff er 
within subgroups. While this issue was 
examined extensively in the course of the 
study by Zhang  et al. , 4 it is worth pointing 
out that searching more and more eff ect 
modifi ers must necessarily increase the 
chance of spurious fi ndings in subgroups 
where eff ects diff er from those in the par-
ent population. 
 It would be desirable to confi rm these 
observational findings with properly 
designed randomized controlled trials. 
For example, these studies suggest that a 
trial of alternate-day versus conventional 
three-times-weekly hemodialysis is 
needed. In all these studies, the excess 
mortality on the day of the long interdia-
lytic interval appears substantial. How-
ever, it may be worth pointing out that an 
excess mortality measured as  x on a single 
day of the week is equivalent to an excess 
of  x / 7 for mortality in all time frames. In 
the study by Foley  et al. , 3 eff ect sizes for 
cardiovascular hospitalizations were much 
larger than those for death. Incorporating 
both death and cardiovascular hospitali-
zations into a single composite outcome 
might be more realistic for such a study. 
In the meantime, while randomized trials 
are being considered, observational stud-
ies examining hospitalization would be 
useful. 
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 Figure 1  |  Relative risks with the weekly average as the reference and with the average of 
Tuesday to Sunday as the reference. 
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 Calcium balance in chronic kidney 
disease: walking the tightrope 
 Pieter  Evenepoel 1 ,  Liesbeth  Viaene 1 and  Bjorn  Meijers 1 
 Calcium supplements for prevention and treatment of mineral and bone 
disorders in chronic kidney disease (CKD) have been alternately praised 
and damned. Clinical evidence in favor of either attitude has been 
lacking. The calcium balance study by Spiegel and Brady in patients with 
late stage 3 and stage 4 CKD suggests that CKD subjects ingesting 
2000  mg of elemental calcium per day are in marked positive balance. 
Methodological limitations such as unproven steady state warrant 
caution and confirmatory studies. 
 Kidney International (2012)  81, 1057 – 1059.  doi: 10.1038/ki.2012.33 
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 Calcium is an essential nutrient that plays 
a vital role in neuromuscular function, 
many enzyme-mediated processes, and 
blood clotting and provides skeletal rigid-
ity by virtue of its phosphate salts. Its 
non-structural roles require the strict 
maintenance of ionized calcium concen-
tration in tissue fl uids, if necessary, at the 
expense of the skeleton. Calcium defi -
ciency has been known for many years to 
jeopardize the skeleton in the long term. 
Recently, concerns have also grown that 
calcium supply in excess of the require-
ments may increase cardiovascular risk. 1 
Avoiding calcium defi ciency and over-
load, thus, is of utmost importance. 
 In normal adults, the rate of calcium 
absorption from the gastrointestinal tract 
matches the rate of losses from the body 
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through the bowel, kidneys, skin, hair, and 
nails; that is, calcium balance is neutral 
( Figure 1 ). Age, bone disease, hormonal 
status, and exercise have all been shown 
to aff ect calcium balance. 2 An impaired 
gastrointestinal absorption, related to low 
1,25-dihydroxyvitamin D 3 levels, and a 
decreased renal excretory capacity may 
render chronic kidney disease (CKD) 
patients at risk for either a negative or a 
positive calcium balance. However, stud-
ies investigating calcium balance in CKD 
are scant, probably because balance stud-
ies are labor-intensive and demanding. 
Th e new study by Spiegel and Brady 3 (this 
issue), therefore, is highly welcomed. 
Th ese investigators performed balance 
studies in six patients with late stage 3 and 
stage 4 CKD and six control subjects con-
suming an 800- and a 2000-mg elemental 
calcium diet. Classical balance studies 
provide data for apparent absorption 
(intake minus fecal) and net retention 
(intake minus fecal minus urinary) and 
the corresponding coeffi  cients. Th e main 
fi nding of the study is that CKD patients 
and healthy controls are in markedly pos-
itive calcium balance when ingesting 
2000  mg elemental calcium, with calcium 
balance being signifi cantly greater in CKD 
patients than in controls (759 versus 
464  mg / d, mean). When ingesting an 800-
mg calcium diet, conversely, both CKD 
patients and controls were in neutral to 
slightly negative calcium balance. On the 
basis of these observations the authors 
conclude that total elemental calcium 
intake should be within 800 – 1200  mg / d to 
prevent calcium defi ciency and calcium 
loading, respectively. Th is implies that 
calcium supplements and calcium-con-
taining phosphate binders are virtually 
completely to be avoided in CKD, even in 
patients not yet on dialysis. Is the evidence 
strong enough to support such a far-
reaching conclusion? Several questions 
need to be raised and warrant caution. 
 A fi rst question to be asked is whether 
or not the study participants were in 
steady state during calcium loading. It is 
well accepted that balances can be assessed 
only when patients are in steady state, that 
is, in the absence of major fl uctuations in 
the homeostatic processes. Balance stud-
ies thus require suffi  cient equilibration 
time. A key question is what is suffi  cient 
time. Although there is no strong guid-
ance from the literature, the 7-day equili-
bration period in the study by Spiegel and 
Brady 3 is rather short and might have 
been too short. Th e mean duration of bal-
ances in 210 studies from eight publica-
tions used in a recent report from the 
Food and Agriculture Association of the 
United Nations and the World Health 
Organization was 90 days. 4 Uncertainty as 
to whether a steady state is reached during 
calcium loading should especially caution 
against long-term extrapolation. Extrapo-
lating from current data, a CKD patient 
treated with 4  g of calcium carbonate 
(1600  mg elemental calcium) would 
accrue approximately 2.8  kg elemental 
calcium over a 10-year time span. Th is 
amount of elemental calcium corresponds 
to about 6.8  kg of hydroxyapatite (1  mol 
Ca 10 (PO 4 ) 6 (OH) 2  =  1004  g; 1  mol Ca  = 
40  g), that is, roughly half the weight of the 
skeleton of a 68-kg person, which is hard 
to believe. Th ese kinds of calculations, 
although tricky, at least raise doubts. 
Nonetheless, preliminary data from a 
